Burning Rock Biotech Limited Sponsored ADR (BNR) vs MBody AI Ltd. (MBAI)

Burning Rock Biotech Limited Sponsored ADR and MBody AI Ltd. are both Diagnostics & Research companies. Burning Rock Biotech Limited Sponsored ADR is the larger, with a market value of $137.1M against $47.4M — 2.9× the size. MBody AI Ltd. has the higher net margin (0.00% vs −13.5%) and the higher return on invested capital (0.00% vs −50.7%). Across the 14 metrics below, MBody AI Ltd. leads on 10 and Burning Rock Biotech Limited Sponsored ADR on 4.

Valuation

Metric BNR MBAI Diagnostics & Research median
P/E n/m n/m 35.56
P/S 18.73 n/m 4.37
P/B 18.81 0.61 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 17.89 n/m 5.51
Earnings yield (4.09%) (763.41%) (1.89%)
Free cash flow yield (1.06%) (565.34%) (0.15%)

Profitability

Metric BNR MBAI Diagnostics & Research median
Gross margin 74.50% 0.00% 50.89%
Operating margin (12.95%) 0.00% (8.57%)
Net margin (13.51%) 0.00% (6.37%)
Free cash flow margin (3.00%) 0.00% 0.00%
Return on equity (13.08%) 0.00% (2.92%)
Return on assets (8.81%) 0.00% (6.71%)
Return on invested capital (50.66%) 0.00% 0.00%

Growth

Metric BNR MBAI Diagnostics & Research median
Revenue growth (TTM) (0.14%) — 7.69%
EPS growth (last fiscal year) 84.16% 115.35% 25.92%
Revenue growth, 5-year CAGR 3.21% — 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNR MBAI Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 3.05 0.71 2.02
Net debt to EBITDA 14.48 0.09 0.70

Dividend

Metric BNR MBAI Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric BNR MBAI Diagnostics & Research median
Market cap 137.12m 47.41m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack